Bank of America Corp DE Has $19.98 Million Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Bank of America Corp DE lifted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 5.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,021,763 shares of the company's stock after acquiring an additional 49,389 shares during the period. Bank of America Corp DE owned 0.85% of Privia Health Group worth $19,975,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of PRVA. Quadrant Capital Group LLC grew its holdings in shares of Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock valued at $95,000 after acquiring an additional 511 shares in the last quarter. Park Avenue Securities LLC boosted its position in shares of Privia Health Group by 3.8% during the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company's stock worth $287,000 after purchasing an additional 532 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Privia Health Group by 8.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock valued at $140,000 after buying an additional 533 shares during the last quarter. First Horizon Advisors Inc. increased its position in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after buying an additional 632 shares during the period. Finally, Summit Investment Advisors Inc. increased its position in shares of Privia Health Group by 6.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company's stock worth $209,000 after purchasing an additional 678 shares during the period. Institutional investors and hedge funds own 94.48% of the company's stock.

Privia Health Group Price Performance

PRVA stock traded down $0.24 during trading hours on Friday, reaching $22.86. 625,866 shares of the stock were exchanged, compared to its average volume of 738,925. The company has a market cap of $2.79 billion, a price-to-earnings ratio of 228.62, a PEG ratio of 3.47 and a beta of 0.87. The firm's 50-day moving average is $23.39 and its 200-day moving average is $22.70. Privia Health Group, Inc. has a 12 month low of $16.37 and a 12 month high of $26.09.

Insider Activity

In other Privia Health Group news, CEO Parth Mehrotra sold 15,100 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $352,283.00. Following the completion of the sale, the chief executive officer now owns 454,281 shares in the company, valued at approximately $10,598,375.73. This trade represents a 3.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Matthew Shawn Morris sold 10,309 shares of the firm's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total transaction of $240,508.97. Following the completion of the transaction, the director now directly owns 59,792 shares of the company's stock, valued at approximately $1,394,947.36. The trade was a 14.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,579 shares of company stock worth $1,226,367. Corporate insiders own 10.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on PRVA. Canaccord Genuity Group upped their price target on Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research report on Friday, February 28th. Barclays boosted their target price on Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a research report on Thursday, April 10th. Piper Sandler increased their price target on Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research note on Friday, February 28th. Truist Financial raised their price objective on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a report on Thursday, April 10th. Finally, Needham & Company LLC reissued a "buy" rating and set a $30.00 target price on shares of Privia Health Group in a research note on Thursday, April 10th. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $27.38.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.